B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

FAAH2

MOLECULAR TARGET

fatty acid amide hydrolase 2

UniProt: Q6GMR7NCBI Gene: 1585842 compounds

FAAH2 (fatty acid amide hydrolase 2) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting FAAH2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1urb 5974.0858
2cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester [Supplementary Concept]1.393

About FAAH2 as a Drug Target

FAAH2 (fatty acid amide hydrolase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented FAAH2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

FAAH2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.